Injectable: DepoBupivacaine

Extended release formulation of bupivacaine local anaesthetic

Pilot clinical study completedLocal anaesthetic effect exceeded 48 hours

Filing IND and starting full-scale US clinical studies in 2002

Option granted to undisclosed major pharmaceutical company regarding future marketing rights

(Proprietary product)

Previous slide

Next slide

Back to first slide

View graphic version